|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.178
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.148
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.141
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.108
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.105
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.105
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.104
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.100
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.099
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.091
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.080
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.078
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.078
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.078
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.077
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.070
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.069
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.067
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.067
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.067
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.067
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.067
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.066
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.066
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.065
|
Mouse |
|
|
skeletal system development
|
GO:0001501 |
356 |
0.065
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.065
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.063
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.063
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.063
|
Worm |
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.062
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.061
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.061
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.060
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.060
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.059
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.059
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.058
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.058
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.056
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.055
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.055
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.055
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.053
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.052
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.052
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.051
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.051
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.049
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.049
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.049
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.048
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.047
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.046
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.046
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.046
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.045
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.044
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.043
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.043
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.043
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.042
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.042
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.042
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.041
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.041
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.041
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.041
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.041
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.041
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.040
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.040
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.040
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.040
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.040
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.039
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.039
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.037
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.037
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.037
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.037
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.036
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.036
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.036
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.036
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.035
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.035
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.035
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.034
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.034
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.034
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.034
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.034
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.034
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.033
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.033
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.033
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.033
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.033
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.033
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.033
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.033
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.033
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.032
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.032
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.032
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.032
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.032
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.032
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.032
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.031
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.031
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.031
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.031
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.031
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.031
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.031
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.030
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.030
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.030
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.030
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.030
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.030
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.030
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.030
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.030
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.030
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.030
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.029
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.029
|
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
28 |
0.029
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.029
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.029
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.029
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.029
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.028
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.028
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.028
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.028
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.028
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.028
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.028
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.028
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.028
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.027
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.027
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.027
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.027
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.027
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.027
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.027
|
|
|
|
renal vesicle development
|
GO:0072087 |
17 |
0.027
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.027
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.027
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.027
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.027
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.026
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.026
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.026
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.026
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.026
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.026
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.026
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.026
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.025
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.025
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.025
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.025
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.025
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.025
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.025
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.025
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.025
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.024
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.024
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.024
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.024
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.024
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.024
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.024
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.024
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.024
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.024
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.024
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.024
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.024
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.023
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.023
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.023
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.023
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.023
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.023
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.023
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.023
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.023
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.023
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.023
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.023
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.023
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.023
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.023
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.023
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.023
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.022
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.022
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.022
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.022
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.022
|
Worm |
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.022
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.022
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.022
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.022
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.022
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.022
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.022
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.022
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.022
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.022
|
|
|
|
regulation of extracellular matrix assembly
|
GO:1901201 |
2 |
0.022
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.021
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.021
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.021
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.021
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.021
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.021
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.021
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.021
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.021
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.021
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.021
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.021
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.021
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.021
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.021
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.021
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.021
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.021
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.020
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.020
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.020
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.020
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.020
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.020
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.020
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.020
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.020
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.020
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.020
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.020
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.020
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.020
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.020
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.020
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.020
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.020
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.019
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.019
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.019
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.019
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.019
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.019
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.019
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.019
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.019
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.019
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.019
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.019
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.019
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.019
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.019
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.019
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.019
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.019
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.019
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.018
|
Worm |
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.018
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.018
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.018
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.018
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.018
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.018
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.018
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.018
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.018
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.018
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.018
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.018
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.018
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.018
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.018
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.018
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.018
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.018
|
Mouse |
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.018
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.018
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.018
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.018
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.018
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.018
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.018
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.018
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.018
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.018
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.018
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.018
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.017
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.017
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.017
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.017
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.017
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.017
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.017
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.017
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.017
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.017
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.017
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.017
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.017
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.017
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.017
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.017
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.017
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.017
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.017
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.017
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.017
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.017
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.017
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.017
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.017
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.017
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.017
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.017
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.017
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.016
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.016
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.016
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.016
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.016
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.016
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.016
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.016
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.016
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.016
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.016
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.016
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.016
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.016
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.016
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.016
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.016
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.016
|
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.016
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.016
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.016
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.016
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.016
|
Worm |
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.016
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.016
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.016
|
|
|
|
renal vesicle morphogenesis
|
GO:0072077 |
15 |
0.016
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.016
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.016
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.016
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.015
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.015
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.015
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.015
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.015
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.015
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.015
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.015
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.015
|
|
|
|
positive regulation of inositol phosphate biosynthetic process
|
GO:0060732 |
2 |
0.015
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.015
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.015
|
Worm |
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.015
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.015
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.015
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.015
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.015
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.015
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.015
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.015
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.015
|
|
|
|
compartment pattern specification
|
GO:0007386 |
4 |
0.015
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.015
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.015
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.015
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.015
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.015
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.015
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.015
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.015
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.015
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.015
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.015
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.015
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.015
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.015
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.015
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.015
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.015
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.015
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.015
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.015
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.014
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.014
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.014
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.014
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.014
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.014
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.014
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.014
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.014
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.014
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.014
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.014
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.014
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.014
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.014
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.014
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.014
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.014
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.014
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.014
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.014
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.014
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.014
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.014
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.014
|
Worm |
|
|
response to insulin
|
GO:0032868 |
100 |
0.014
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.014
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.014
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.014
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.014
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.014
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.014
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.014
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.014
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.014
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.014
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.014
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.014
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.014
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.014
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.013
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.013
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.013
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.013
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.013
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.013
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.013
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.013
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.013
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.013
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.013
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.013
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.013
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.013
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.013
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.013
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.013
|
|
|
|
sensory perception of chemical stimulus
|
GO:0007606 |
51 |
0.013
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.013
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.013
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.013
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.013
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.013
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.013
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.013
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.013
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.013
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.013
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.013
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.013
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.013
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.013
|
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
17 |
0.013
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.013
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.013
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.013
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.013
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.013
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.013
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.013
|
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
31 |
0.013
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.013
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.013
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.012
|
|
|
|
positive regulation of axon extension
|
GO:0045773 |
20 |
0.012
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.012
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.012
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.012
|
|
|
|
cell cell junction assembly
|
GO:0007043 |
27 |
0.012
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.012
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.012
|
|
